Company profile: DNA Script
1.1 - Company Overview
Company description
- Provider of enzymatic DNA synthesis solutions, featuring the SYNTAX benchtop DNA printer for on-demand custom oligo production up to 120 nucleotides using Enzymatic DNA Synthesis (EDS). Offers SYNTAX 96 Hi-Fidelity and 96 Standard kits for 96 oligos (up to 120 nt or 80 nt), the SYNTAX 192 Label Kit for probes with up to two labels for qPCR and FISH, and SYNTAX Labels including fluorophores, quenchers, and biotin.
Products and services
- SYNTAX 192 Label Kit: SYNTAX-compatible kit creates labeled DNA probes, supporting incorporation of up to two labels per probe for qPCR and FISH workflows
- SYNTAX 96 Hi-Fidelity Kits: High-accuracy kits supply reagents and consumables to synthesize 96 custom DNA oligos up to 120 nucleotides, supporting applications demanding elevated sequence accuracy
- SYNTAX System: Benchtop DNA printer enables on-demand synthesis of custom oligos using Enzymatic DNA Synthesis (EDS), producing sequences up to 120 nucleotides for faster results and tighter workflow control.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DNA Script
Vigene Biosciences
HQ: United States
Website
- Description: Provider of gene delivery technologies and cell and gene therapy CDMO solutions, offering research- and cGMP-grade AAV, lentivirus, and adenovirus products and custom services, including ready-to-ship genome-wide human cDNA ORFs on adenoviral or lentiviral, supporting therapy development and production to advance biomedical research and make gene therapy affordable.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vigene Biosciences company profile →
BioChain
HQ: United States
Website
- Description: Provider of technology and products for the life science research community, including cfPure® cell-free DNA extraction kits to isolate cfDNA from plasma, serum, and urine for NGS and PCR; high-quality biospecimens; reagents; pre-packaged laboratory kits; and automated instruments to automate processes and enhance efficiency in sample preparation and analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioChain company profile →
Passage Bio
HQ: United States
Website
- Description: Provider of fully integrated gene therapy development focused on treatments for monogenic central nervous system diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Passage Bio company profile →
Fabric Genomics
HQ: United States
Website
- Description: Provider of genomics-driven precision medicine software, delivering end-to-end genomic analysis, interpretation, and clinical reporting for clinical labs, hospital systems, and country-sequencing programs. Powers actionable genomic insights to enable faster, more accurate diagnoses, featuring AI algorithms including GEM, VAAST, and Phevor for disease gene and phenotype-driven variant ranking.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fabric Genomics company profile →
GeneTether
HQ: United States
Website
- Description: Provider of genome editing enhancement platforms that tether or conjugate donor DNA templates to editing complexes, including the GeneTether Platform and TNT technology to boost DNA insertion efficiency with targeted tools like CRISPR-Cas, and pursuing strategic partnerships in human therapeutics, animal health, agriculture, and cell delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneTether company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DNA Script
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DNA Script
2.2 - Growth funds investing in similar companies to DNA Script
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DNA Script
4.2 - Public trading comparable groups for DNA Script
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →